Evidence map›Paper›PMID 23142346›Full record

ArticleStructure (London, England : 1993)2012

Structural mechanisms of allostery and autoinhibition in JNK family kinases.

John D Laughlin, Jerome C Nwachukwu, Mariana Figuera-Losada, Lisa Cherry, Kendall W Nettles, Philip V LoGrasso

Open access · bronzeAbstract read
In one paragraph

Article in Structure (London, England : 1993), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Bipartite binding of the intrinsically disordered scaffold protein JIP1 to the kinase JNK1.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. C-Jun N-terminal kinase inhibitors: Structural insight into kinase-inhibitor complexes.Computational and structural biotechnology journal · 2020
    Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

John D LaughlinDepartment of Molecular Therapeutics, The Scripps Research Institute, 130 Scripps Way, Jupiter, FL 33458, USA.
Jerome C Nwachukwu
Mariana Figuera-Losada
Lisa Cherry
Kendall W Nettles
Philip V LoGrasso
Scripps Research Institute · US

Funding

Preclinical Development of JNK3 Inhibitors to Treat Parkinson's DiseaseU01NS057153 · NINDS · SCRIPPS RESEARCH INSTITUTE, THE · PI LOGRASSO, PHILIP · 2008 to 2012
$7.7M
NINDS NIH HHS NS057153NINDS NIH HHS U01 NS057153
6 · The paper itself

Abstract

c-Jun N-terminal (JNK) family kinases have a common peptide-docking site used by upstream activating kinases, substrates, scaffold proteins, and phosphatases, where the ensemble of bound proteins determines signaling output. Although there are many JNK structures, little is known about mechanisms of allosteric regulation between the catalytic and peptide-binding sites, and the activation loop, whose phosphorylation is required for catalytic activity. Here, we compare three structures of unliganded JNK3 bound to different peptides. These were compared as a class to structures that differ in binding of peptide, small molecule ligand, or conformation of the kinase activation loop. Peptide binding induced an inhibitory interlobe conformer that was reversed by alterations in the activation loop. Structure class analysis revealed the subtle structural mechanisms for allosteric signaling between the peptide-binding site and activation loop. Biochemical data from isothermal calorimetry, fluorescence energy transfer, and enzyme inhibition demonstrated affinity differences among the three peptides that were consistent with structural observations.

Indexed as

Activating Transcription Factor 2Adaptor Proteins, Signal TransducingAllosteric RegulationAmino Acid MotifsAmino Acid SequenceCatalytic DomainCrystallography, X-RayHumansMitogen-Activated Protein Kinase 10Mitogen-Activated Protein Kinase 8Models, MolecularOligopeptidesProtein BindingProtein Kinase InhibitorsProtein Structure, SecondarySubstrate SpecificityActivating Transcription Factor 2Adaptor Proteins, Signal TransducingATF2 protein, humanMAPK8IP1 protein, humanMitogen-Activated Protein Kinase 10Mitogen-Activated Protein Kinase 8OligopeptidesProtein Kinase InhibitorsSH3BP5 protein, human

Identifiers

PMID23142346
PMCPMC3589125
OpenAlexW2016008760

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.